$INBS News

Intelligent Bio Solutions Inc. (INBS) Discusses FDA 510(k) Submission and Progress of Intelligent Fingerprinting Drug Screening System Transcript

Intelligent Bio Solutions Registers 6,211,809 Shares Of Common Stock For Resale Underlying Warrants

Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET

Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market

Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance

Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission

Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules

UPDATE: Intelligent Bio Solutions Commences ~$5M Placement Of Common Shares, Warrants At Combined Price Of $2.455 Per Share

Intelligent Bio Solutions Reports 98.2% Accuracy In Codeine Study, Accelerates FDA 510(k) Submission To September 2026

Intelligent Bio Solutions Commences ~$M Placement Of Common Shares, Warrants At Combined Price Of $2.455 Per Share

Intelligent Bio Solutions' Intelligent Fingerprinting Limited Has Been Granted European Patent Number EP3497617 Titled "SKINPRINT ANALYSIS METHOD AND APPARATUS".

Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth

Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action?

Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification

Intelligent Bio Solutions' Intelligent Fingerprinting Drug Screening Business Has Been ISO Recertified To The 13485:2016 Quality Management System Standard And Will Be Valid For Three Years

Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System

Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission

Intelligent Bio Solutions Completes Usability Study For Intelligent Fingerprinting Drug Screening System To Detect Opiate Codeine

Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System

Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry